Toward an interdisciplinary science of adolescence: Insights from schizophrenia research

Neuroscience Research

Volumn 75, Issue 2, 2013, Pages 89-93

  Kasai, Kiyoto ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Adolescence; Development; Neuroimaging; Prefrontal; Schizophrenia; Self regulation; Synapse; Translatable

Indexed keywords

ARTICLE; AUTOREGULATION; DENDRITIC SPINE; DEPRESSION; EARLY DIAGNOSIS; EARLY INTERVENTION; EDUCATION; HIGH RISK PATIENT; HUMAN; INTERDISCIPLINARY RESEARCH; MENTAL FUNCTION; MOOD DISORDER; NEUROIMAGING; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SOCIETY;

ADOLESCENT; ANIMALS; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; HUMANS; MENTAL DISORDERS; SCHIZOPHRENIA; SOCIAL CONTROL, INFORMAL;

EID: 84875376762     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2012.12.001     Document Type: Article

References (73)

1. Adolescent Emotional Development and the Emergence of Depressive Disorders 2008, Cambridge University Press, Cambridge, UK. N.B. Allen, L.B. Sheeber (Eds.).
2. Amann L.C., Gandal M.J., Halene T.B., Ehrlichman R.S., White S.L., McCarren H.S., Siegel S.J. Mouse behavioral endophenotypes for schizophrenia. Brain Res. Bull. 2010, 83:147-161.
3. Amminger G.P., Schafer M.R., Papageorgiou K., Klier C.M., Cotton S.M., Harrigan S.M., Mackinnon A., McGorry P.D., Berger G.E. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 2010, 66:700-712.
4. Andreasen N.C., Nopoulos P., Magnotta V., Pierson R., Ziebell S., Ho B.C. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol. Psychiatry 2011, 70:672-679.
5. Atkinson R.J., Michie P.T., Schall U. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biol. Psychiatry 2012, 71:98-104.
6. Beddington J., Cooper C.L., Field J., Goswami U., Huppert F.A., Jenkins R., Jones H.S., Kirkwood T.B., Sahakian B.J., Thomas S.M. The mental wealth of nations. Nature 2008, 455:1057-1060.
7. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., Quinlan E.M., Nakazawa K. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 2010, 13:76-83.
8. Cahill M.E., Xie Z., Day M., Photowala H., Barbolina M.V., Miller C.A., Weiss C., Radulovic J., Sweatt J.D., Disterhoft J.F., Surmeier D.J., Penzes P. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13058-13063.
9. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65:28-37.
10. Casey B.J., Duhoux S., Malter Cohen M. Adolescence: what do transmission, transition, and translation have to do with it?. Neuron 2010, 67:749-760.
11. Catts S.V., Shelley A.M., Ward P.B., Liebert B., McConaghy N., Andrews S., Michie P.T. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am. J. Psychiatry 1995, 152:213-219.
12. Chuang N., Mori S., Yamamoto A., Jiang H., Ye X., Xu X., Richards L.J., Nathans J., Miller M.I., Toga A.W., Sidman R.L., Zhang J. An MRI-based atlas and database of the developing mouse brain. Neuroimage 2011, 54:80-89.
13. Cyranoski D. Thought experiment. Nature 2011, 469:148-149.
14. DeLisi L.E. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr. Bull. 2008, 34:312-321.
15. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
16. Glausier J.R., Lewis D.A. Dendritic spine pathology in schizophrenia. Neuroscience 2012, [Epub ahead of print].
17. Gonzalez-Burgos G., Lewis D.A. NMDA receptor hypofunction, parvalbumin-positive neurons and cortical gamma oscillations in schizophrenia. Schizophr. Bull. 2012, 38:950-957.
18. Gore F.M., Bloem P.J., Patton G.C., Ferguson J., Joseph V., Coffey C., Sawyer S.M., Mathers C.D. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet 2011, 377:2093-2102.
19. Gustavsson A., Svensson M., Jacobi F., Allgulander C., Alonso J., Beghi E., Dodel R., Ekman M., Faravelli C., Fratiglioni L., Gannon B., Jones D.H., Jennum P., Jordanova A., Jönsson L., Karampampa K., Knapp M., Kobelt G., Kurth T., Lieb R., Linde M., Ljungcrantz C., Maercker A., Melin B., Moscarelli M., Musayev A., Norwood F., Preisig M., Pugliatti M., Rehm J., Salvador-Carulla L., Schlehofer B., Simon R., Steinhausen H.C., Stovner L.J., Vallat J.M., Van den Bergh P., van Os J., Vos P., Xu W., Wittchen H.U., Jönsson B., Olesen J. Cost of disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 2011, 21:718-779. CDBE2010Study Group.
20. Hayashi-Takagi A., Sawa A. Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment. Brain Res. Bull. 2010, 83:140-146.
21. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A.J., Makino Y., Seshadri A.J., Ishizuka K., Srivastava D.P., Xie Z., Baraban J.M., Houslay M.D., Tomoda T., Brandon N.J., Kamiya A., Yan Z., Penzes P., Sawa A. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 2010, 13:327-332.
22. International early psychosis association writing group, 2005. International clinical practice guidelines for early psychosis. Br. J. Psychiatry 187, 120-124.
23. Iritani S. Neuropathology of schizophrenia: a mini review. Neuropathology 2007, 27:604-608.
24. Iwashiro N., Suga M., Takano Y., Inoue H., Natsubori T., Satomura Y., Koike S., Yahata N., Murakami M., Katsura M., Gonoi W., Sasaki H., Takao H., Abe O., Kasai K., Yamasue H. Localized gray matter volume reductions in the pars triangularis of the inferior frontal gyrus in individuals at clinical high-risk for psychosis and first episode for schizophrenia. Schizophr. Res. 2012, 137:124-131.
25. Javitt D.C., Steinschneider M., Schroeder C.E., Arezzo J.C. Role of cortical N-methyl-d-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:11962-11967.
26. Javitt D.C., Spencer K.M., Thaker G.K., Winterer G., Hajós M. Neurophysiological biomarkers for drug development in schizophrenia. Nat. Rev. Drug Discov. 2008, 7:68-83.
27. Kameyama M., Fukuda M., Yamagishi Y., Sato T., Uehara T., Ito M., Suto T., Mikuni M. Frontal lobe function in bipolar disorder: a multichannel near-infrared spectroscopy study. Neuroimage 2006, 29:172-184.
28. Kasai K., Okazawa K., Nakagome K., Hiramatsu K., Hata A., Fukuda M., Honda M., Miyauchi M., Matsushita M. Mismatch negativity and N2b attenuation as an indicator for dysfunction of the preattentive and controlled processing for deviance detection in schizophrenia: a topographic event-related potential study. Schizophr. Res. 1999, 35:141-156.
29. Kasai K., Nakagome K., Itoh K., Koshida I., Hata A., Iwanami A., Fukuda M., Kato N. Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: a high-resolution event-related potential study. Am. J. Psychiatry 2002, 159:546-553.
30. Kasai K., Iwanami A., Yamasue H., Kuroki N., Nakagome K., Fukuda M. Neuroanatomy and neurophysiology in schizophrenia. Neurosci. Res. 2002, 43:93-110.
31. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Lee C.U., Ciszewski A.A., Yurgelun-Todd D., Kikinis R., Jolesz F.A., McCarley R.W. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am. J. Psychiatry 2003, 160:156-164.
32. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Spencer M.H., Yurgelun-Todd D.A., Kikinis R., Jolesz F.A., McCarley R.W. Progressive decrease of left Heschl gyrus & planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 2003, 60:766-775.
33. Kawakami N., Takeshima T., Ono Y., Uda H., Hata Y., Nakane Y., Nakane H., Iwata N., Furukawa T.A., Kikkawa T. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatry Clin. Neurosci. 2005, 59:441-452.
34. Kawakubo Y., Suga M., Tochigi M., Yumoto M., Itoh K., Sasaki T., Kano Y., Kasai K. Effects of metabotropic glutamate receptor 3 genotype on phonetic mismatch negativity. PLoS One 2011, 6:e24929.
35. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
36. Kieling C., Baker-Henningham H., Belfer M., Conti G., Ertem I., Omigbodun O., Rohde L.A., Srinath S., Ulkuer N., Rahman A. Child and adolescent mental health worldwide: evidence for action. Lancet 2011, 378:1515-1525.
37. Koike S., Takizawa R., Nishimura Y., Takano Y., Takayanagi Y., Kinou M., Araki T., Harima H., Fukuda M., Okazaki Y., Kasai K. Different hemodynamic response patterns in the prefrontal cortical sub-regions according to the clinical stages of psychosis. Schizophr. Res. 2011, 132:54-61.
38. Konradi C., Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol. Ther. 2003, 97:153-179.
39. Lederbogen F., Kirsch P., Haddad L., Streit F., Tost H., Schuch P., Wüst S., Pruessner J.C., Rietschel M., Deuschle M., Meyer-Lindenberg A. City living and urban upbringing affect neural social stress processing in humans. Nature 2011, 474:498-501.
40. Malone D.T., Hill M.N., Rubino T. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br. J. Pharmacol. 2010, 160:511-522.
41. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 2005, 62:975-983.
42. McGorry P.D., Hickie I.B., Yung A.R., Pantelis C., Jackson H.J. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. N. Z. J. Psychiatry 2006, 40:616-622.
43. Michie P.T., Budd T.W., Todd J., Rock D., Wichmann H., Box J., Jablensky A.V. Duration and frequency mismatch negativity in schizophrenia. Clin. Neurophysiol. 2000, 111:1054-1065.
44. Morrison A.P., French P., Stewart S.L., Birchwood M., Fowler D., Gumley A.I., Jones P.B., Bentall R.P., Lewis S.W., Murray G.K., Patterson P., Brunet K., Conroy J., Parker S., Reilly T., Byrne R., Davies L.M., Dunn G. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 2012, 344:e2233.
45. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., Koo M.S., Shenton M.E., McCarley R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry 2007, 62:773-783.
46. Nature, editorial, 2010. A decade for psychiatric disorders. Nature 463, 9.
47. Nishida A., Tanii H., Nishimura Y., Kajiki N., Inoue K., Okada M., Sasaki T., Okazaki Y. Association between psychotic-like experiences and mental health status and other psychopathologies among Japanese early teens. Schizophr. Res. 2008, 99:125-133.
48. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
49. Patton G.C., Viner R. Pubertal transitions in health. Lancet 2007, 369:1130-1139.
50. Paus T., Keshavan M., Giedd J.N. Why do many psychiatric disorders emerge during adolescence?. Nat. Rev. Neurosci. 2008, 9:947-957.
51. Pearson H. Epidemiology: study of a lifetime. Nature 2011, 471:20-24.
52. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 2005, 162:1785-1804.
53. Poulton R., Caspi A., Moffitt T.E., Cannon M., Murray R., Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch. Gen. Psychiatry 2000, 57:1053-1058.
54. Prince M., Patel V., Saxena S., Maj M., Maselko J., Phillips M.R., Rahman A. No health without mental health. Lancet 2007, 370:859-877.
55. Adolescent Psychopathology and the Developing Brain: Integrating Brain and Prevention Science 2007, Oxford University Press, New York. D. Romer, E.F. Walker (Eds.).
56. Salisbury D.F., Shenton M.E., Griggs C.B., Bonner-Jackson A., McCarley R.W. Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Arch. Gen. Psychiatry 2002, 59:686-694.
57. Salisbury D.F., Kuroki N., Kasai K., Shenton M.E., McCarley R.W. Progressive and interrelated functional and structural evidence for post-onset brain reduction in schizophrenia. Arch. Gen. Psychiatry 2007, 64:521-529.
58. Shelley A.M., Ward P.B., Catts S.V., Michie P.T., Andrews S., McConaghy N. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol. Psychiatry 1991, 30:1059-1062.
59. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49:149-200.
60. Sun D., Phillips L., Velakoulis D., Yung A., McGorry P.D., Wood S.J., van Erp T.G., Thompson P.M., Toga A.W., Cannon T.D., Pantelis C. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 2009, 108:85-92.
61. Suto T., Fukuda M., Ito M., Uehara T., Mikuni M. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study. Biol. Psychiatry 2004, 55:501-511.
62. Sweet R.A., Henteleff R.A., Zhang W. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2009, 34:374-389.
63. Takahashi T., Wood S.J., Yung A.R., Soulsby B., McGorry P.D., Suzuki M., Kawasaki Y., Phillips L.J., Velakoulis D., Pantelis C. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch. Gen. Psychiatry 2009, 66:366-376.
64. Takahashi T., Suzuki M., Zhou S.Y., Tanino R., Nakamura K., Kawasaki Y., Seto H., Kurachi M. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia. Schizophr. Res. 2010, 119:65-74.
65. Takizawa R., Kasai K., Kawakubo Y., Marumo K., Kawasaki S., Yamasue H., Fukuda M. Reduced frontopolar activation during verbal fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study. Schizophr. Res. 2008, 99:250-262.
66. Teffer K., Semendeferi K. Human prefrontal cortex: evolution, development, and pathology. Prog. Brain Res. 2012, 195:191-218.
67. Uhlhaas P.J. The adolescent brain: implications for the understanding: pathophysiology, and treatment of schizophrenia. Schizophr. Bull. 2011, 37:480-483.
68. Umbricht D., Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr. Res. 2005, 76:1-23.
69. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Brans R., Carati I., Rais M., Kahn R.S. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry 2008, 63:106-113.
70. van Os J., Kenis G., Rutten B.P. The environment and schizophrenia. Nature 2010, 468:203-212.
71. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
72. Weissman M.M., Brown A.S., Talati A. Translational epidemiology in psychiatry: linking population to clinical and basic sciences. Arch. Gen. Psychiatry 2011, 68:600-608.
73. Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson M., Jönsson B., Olesen J., Allgulander C., Alonso J., Faravelli C., Fratiglioni L., Jennum P., Lieb R., Maercker A., van Os J., Preisig M., Salvador-Carulla L., Simon R., Steinhausen H.C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 2011, 21:655-679.